Atlas Trials

Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer

Clinical trial NCT01423123 · COMPLETED

Trial details

NCT number
NCT01423123
Sponsor
NSABP Foundation Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2011-05-01
Primary completion
2012-08-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.